Back to ArticlesThe Carcino Foundation
11 min read•Sep 25, 2026

Liver Cancer: Hepatocellular Carcinoma, BCLC Staging, Resection, Ablation & TACE

S

Soushree Chakraborty | Chief Research Officer

Carcino Research & Clinical Advisory

Liver cancer caused 866,136 new cases in 2022 (10th most common cancer). Hepatocellular Carcinoma (HCC) is the major adult primary liver cancer.

Functions & Causes

Liver functions: Bile production, glycogen energy storage, blood filtration.

Major risk factors: Hepatitis B or C viruses, Cirrhosis scarring, heavy alcohol, NAFLD fatty liver disease.

Symptoms & Red Flags

Hard lump right upper abdomen, right shoulder pain, ascites abdominal swelling, Jaundice (yellow eyes/skin), easy bruising, fatigue, nausea, weight loss, clay-colored stools, dark urine, fever.

BCLC Staging & Advanced Treatments

BCLC Staging: Stage 0 (Very Early) to Stage D (Terminal).

Treatment: Surgical Resection, Liver Transplant, RFA / MWA Thermal Ablation, TACE Chemoembolization, Radioembolization microspheres, Targeted sorafenib/lenvatinib, Immunotherapy atezolizumab/nivolumab, SBRT radiation.

Frequently Asked Questions (FAQs)

Citations & Medical References